Related Experiment Video
Updated: Mar 15, 2026
Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Multidrug-resistant Candida auris: 'new kid on the block' in hospital-associated infections?
A Chowdhary1, A Voss2, J F Meis2
1Department of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.
Abstract:
Since being first reported in an ear swab in 2009, and in blood cultures in 2011, invasive infections with Candida auris have been reported in many countries across several continents. We review current knowledge of the epidemiology of this emerging multidrug-resistant pathogen. The importance of species identification and the inadequacies of many widely used identification systems are considered. We recommend that hospitals develop their own policies for the prevention and control of infections with this pathogen. Elements of such policies and the limitations of the existing knowledge base are discussed.
Insights
Candida auris, a multidrug-resistant fungus, causes invasive infections globally. This review covers its epidemiology, identification challenges, and recommends hospital-specific infection control policies.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Public Health
Background:
- Emergence of Candida auris as a global health threat since 2009.
- Increasing reports of invasive infections across multiple continents.
- Candida auris is a multidrug-resistant fungal pathogen.
Purpose of the Study:
- To review current knowledge on Candida auris epidemiology.
- To highlight challenges in accurate species identification.
- To recommend strategies for infection prevention and control in healthcare settings.
Main Methods:
- Literature review of published studies on Candida auris.
- Analysis of epidemiological data on invasive infections.
- Evaluation of diagnostic methods for Candida auris identification.
Main Results:
- Global spread of Candida auris with diverse resistance patterns.
- Significant limitations in widely used diagnostic systems for accurate identification.
- Need for standardized and validated identification methods.
Conclusions:
- Hospitals must develop tailored policies for Candida auris prevention and control.
- Further research is needed to address knowledge gaps in epidemiology and treatment.
- Improved diagnostic accuracy is crucial for effective management of Candida auris infections.
More Related Videos
03:24Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
Published on: March 22, 2024
06:50A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022
Related Concept Videos
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.